NetworkNewsBreaks Archive - Page 1998 of 2085

FridayMay 05, 2017 12:22 pm

NetworkNewsBreaks – Delta Technology Holdings (NASDAQ: DELT): Hike in Price of Solvent Byproduct Contributes to Sales Growth

Shares of Delta Technology Holdings (NASDAQ: DELT) are up 5% this morning after the company said the price of its solvent has quadrupled over the past 12 months. The solvent, which is one of the company’s principal byproducts, consists primarily of dichlorotoluene. Dichlorotoluene is used in the production of exterior wall coating and industrial glues. “Delta produces between 100 and 300 tons of solvent in OCT/PCT production process every month, and because it's a byproduct, we don't attribute a material cost to its production. As a result, sales of solvent not only contribute to revenue growth, but are also highly…

FridayMay 05, 2017 12:18 pm

NetworkNewsBreaks – Eco Science Solutions, Inc. (ESSI) Inks LOI to Acquire Specialty Banking Operation; Shares Rise

Eco Science Solutions, Inc. (OTCQB: ESSI) shares are up more than 18% after the company this morning said it has signed a Letter of Intent (LOI) with Ga-Du Bank, Inc. for the purpose of acquiring full ownership of the bank in a stock and cash transaction. ESSI will operate the bank as a wholly owned subsidiary upon the closing of the transaction. Furthermore, the company will operate the financial banking division providing payment processing, cash management and financial services to its customers in the cannabis industry. "It has been our vision from day one that, in order to fully service…

FridayMay 05, 2017 12:15 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Yangtze River Development Ltd. (NASDAQ: YERR), Raises PT to $13.25

SeeThruEquity recently issued a company update and raised its price target to $13.25 on shares of Yangtze River Development Ltd. (NASDAQ: YERR). Among other highlights, the analyst notes the company’s uplisting to the Nasdaq Capital Market on April 19, 2017. The analyst believes this demonstrates a successful execution of a significant corporate milestone, and delivers on management's goals from 2016. For more information, visit www.yerr.com.cn About Yangtze River Development Limited Yangtze River Development Limited primarily engages in the business of real estate development with a port logistic project located in the middle reaches of the Yangtze River. Wuhan Newport is a…

FridayMay 05, 2017 12:13 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) on Track to Duplicate Success of Industry Behemoth

Boasting triple-digit year-over-year revenue growth in 2016, National Waste Management Holdings (OTC: NWMH) continues its robust strategic expansion, having acquired, within a span of just over 18 months, Waste Recovery Enterprises, Gateway Rolloff Services, Sivart Services, Northeast Data Destruction & Recycling, and Burts Refuse. The company is successfully following a growth path similar to that of Wayne Huizenga, who founded Waste Management, Inc. (NYSE: WM) in the 1960s and started aggressively buying smaller waste collection services across the United States to create what is now the largest waste management company in the country. “With a focus on further strategic expansion,…

FridayMay 05, 2017 11:10 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses “State of the Company” in Interview on MoneyTV

Specialized holding company Singlepoint, Inc. (OTC: SING) is a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, Singlepoint CEO Greg Lambrecht discusses the ‘State of the Company’, giving prospective shareholders some additional insight into the forward plans of both SinglePoint and its SingleSeed subsidiary. “We’re continuing to stick to our plan – that is to raise funds, acquire companies and get more products that we can sell to dispensaries,” Lambrecht noted in the…

FridayMay 05, 2017 8:58 am

NetworkNewsBreaks – ABcann Global Corporation (ABCN:CA) Appoints W. Brett Wilson to Advisory Board

In a news release issued earlier this week, ABcann Global Corporation (ABCN:CA) announced the appointment of W. Brett Wilson to its advisory board in connection with the company’s acquisition of ABcann Medicinals Inc. Wilson brings extensive experience in financing and building early stage ventures to the Abcann Global team, having previously co-founded highly-regarded investment bank FirstEnergy in 1993. He is also a recognizable television personality known for his role as a “Dragon” on CBC’s award-winning Dragon’s Den program. “Mr. Wilson is a welcome addition to the Company’s Advisory Board,” Aaron Keay, CEO and director of ABcann Global, stated in the…

ThursdayMay 04, 2017 1:25 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on May 4, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NGTF 47.06% – News: Issues shareholder update DSGT 40.00% – News: Secures contract with Nicklaus-Palmer Golf Resort CDNA 29.89% – News: Advances toward CMS coverage for AlloSure NMUS 26.85% – News: Announces $20M Series E Preferred Stock Financing AGEN 16.96% – News: Posts Q1 2017 results and corporate update SQBG 14.79% – News: Posts Q1 2017 results; Enters agreement with QVC, Inc. AMMA 11.52% – News: Signs new fighters; Law Firm files class action…

ThursdayMay 04, 2017 1:25 pm

NetworkNewsBreaks – Aegis Capital Maintains ‘Buy’ Rating on Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)

Aegis Capital has reiterated a ‘Buy’ rating and issued a price target of $25 on shares of Concert Pharmaceuticals, Inc.’s (NASDAQ: CNCE) stock. The news follows the company’s recently reported financial results for the first quarter of 2017, including revenue of $20,000 for the quarter. The analyst noted that because Concert is a clinical stage development company, the firm focuses less on the quarterly financials and more on events surrounding clinical trials and deal announcements. During the first quarter, Concert entered an asset purchase agreement with Vertex Pharmaceuticals (NASDAQ: VRTX) for CTP-656. Per the agreement, Vertex will pay Concert up…

ThursdayMay 04, 2017 1:23 pm

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Reiterated with ‘Buy’ at Aegis Capital

Aegis Capital has reiterated a ‘Buy’ rating and price target of $63 on Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) following the company’s recent financial results for the first quarter ended March 31, 2017. The company reported that cash, cash equivalents, and investments at the end of the quarter totaled $207.9 million. The analyst noted that because Aerie is a clinical stage development company, the firm is more focused on upcoming catalysts than quarterly financials. Catalysts for the company include the completion of the Rocket 4 trial; the upcoming Mercury 2 three-month efficacy and safety readout for Roclatan that is expected in…

ThursdayMay 04, 2017 1:20 pm

NetworkNewsBreaks – Aegis Capital Reiterates ‘Buy’ Rating on Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA)

Following Vanda Pharmaceuticals, Inc.’s (NASDAQ: VNDA) first quarter 2017 results, Aegis Capital has reiterated its ‘Buy’ rating and price target of $24 on shares of the company’s stock. The company reported net product sales of $37.4 million in the first quarter of 2017 and reaffirmed its net product sales guidance for 2017 of $165 million to $175 million. The Aegis analyst noted that the company has expanded its sales team for Fanapt®, which should drive growth in the third and fourth quarter of this year. Data from three trials that the analyst cited as catalysts for the year is also…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks